2nd Quarter - Report

STANTON PARK GROUP for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Patient access to rare and orphan disease therapeutics; FDA regulatory pathways for pharmaceuticals; Awareness of Cystic Fibrosis and Sickle Cell Disease

LobbyistCovered position, as disclosed
JAMES DERDERIAN —
VALERIE HENRY —
JOSEPH RACHINSKY —
ERIN STRAWN —
BRYAN WILLIAM WELLS Policy Advisor, Senator Pat Roberts

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.